Literature DB >> 1381383

Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.

F V Flynn1, M Lapsley, P A Sansom, S L Cohen.   

Abstract

AIM: To determine whether urinary beta 2-glycoprotein-1 assays can provide improved discrimination between chronic renal diseases which are primarily of tubular or glomerular origin.
METHODS: Urinary beta 2-glycoprotein-1, retinol-binding protein, alpha 1-microglobulin, beta 2-microglobulin, N-acetyl-beta-D-glucosa-minidase and albumin were measured in 51 patients with primary glomerular disease, 23 with obstructive nephropathy, and 15 with polycystic kidney disease, and expressed per mmol of creatinine. Plasma beta 2-glycoprotein-1 was assayed in 52 patients and plasma creatinine in all 89. The findings were compared between the diagnostic groups and with previously published data relating to primary tubular disorders.
RESULTS: All 31 patients with plasma creatinine greater than 200 mumol/l excreted increased amounts of beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin, and 29 had increased N-acetyl-beta-D-glucosaminidase; the quantities were generally similar to those found in comparable patients with primary tubular pathology. Among 58 with plasma creatinine concentrations under 200 mumol/l, increases in beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin excretion were less common and much smaller, especially in those with obstructive nephropathy and polycystic disease. The ratios of the excretion of albumin to the other proteins provided the clearest discrimination between the patients with glomerular or tubular malfunction, but an area of overlap was present which embraced those with obstructive nephropathy and polycystic disease.
CONCLUSIONS: Increased excretion of beta 2-glycoprotein-1 due to a raised plasma concentration or diminution of tubular reabsorption, or both, is common in all the forms of renal disease investigated, and both plasma creatinine and urinary albumin must be taken into account when interpreting results. Ratios of urinary albumin: beta 2-glycoprotein-1 greater than 1000 are highly suggestive of primary glomerular disease and those less than 40 of primary tubular disease. Used in this way, beta 2-glycoprotein-1 assays provide superior discrimination between glomerular and tubular malfunction when compared with retinol binding protein but the best discrimination is provided by albumin: alpha 1-microglobulin ratios.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381383      PMCID: PMC495177          DOI: 10.1136/jcp.45.7.561

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  Increased serum activity of beta-n-acetyl-glucoseaminidase in atherosclerosis.

Authors:  F Belfiore; E Napoli; L L Vecchio; A M Rabuazzo
Journal:  Am J Med Sci       Date:  1974-10       Impact factor: 2.378

2.  Urinary beta-hexosaminidase excretion in polycystic kidney disease.

Authors:  P Swedenborg; B Hultberg; H Thysell
Journal:  Acta Med Scand       Date:  1981

3.  Immunochemical quantitation of beta2-glycoprotein I in various diseases.

Authors:  G Cohnen
Journal:  J Lab Clin Med       Date:  1970-02

4.  Diagnostic value of low-molecular mass proteins in serum for the detection of reduced glomerular filtration rate.

Authors:  K Jung; B D Schulze; K Sydow; M Pergande; K Precht; G Schreiber
Journal:  J Clin Chem Clin Biochem       Date:  1987-08

Review 5.  Assessment of renal function: selected developments.

Authors:  F V Flynn
Journal:  Clin Biochem       Date:  1990-02       Impact factor: 3.281

6.  Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria.

Authors:  M D Topping; H W Forster; C Dolman; C M Luczynska; A M Bernard
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

7.  Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; C H Bunker; M Nwankwo; P P Majumder; R E Ferrell
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

8.  beta 2-Microglobulin instability in pathological urine.

Authors:  P G Davey; P Gosling
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

9.  N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.

Authors:  R L Sherman; D E Drayer; B R Leyland-Jones; M M Reidenberg
Journal:  Arch Intern Med       Date:  1983-06

10.  Effect of renal insufficiency on the concentration of free retinol-binding protein in urine and serum.

Authors:  A Bernard; A Vyskocyl; P Mahieu; R Lauwerys
Journal:  Clin Chim Acta       Date:  1988-01-15       Impact factor: 3.786

View more
  7 in total

1.  Identification of diagnostic urinary biomarkers for acute kidney injury.

Authors:  Sanju A Varghese; Thomas B Powell; Michael G Janech; Milos N Budisavljevic; Romesh C Stanislaus; Jonas S Almeida; John M Arthur
Journal:  J Investig Med       Date:  2010-04       Impact factor: 2.895

2.  Clinical and plasma proteomic markers correlating with chronic kidney disease after liver transplantation.

Authors:  J Levitsky; D R Salomon; M Abecassis; P Langfelder; S Horvath; J Friedewald; E Wang; S M Kurian; T Mondala; S Gil; R McDade; K Ballard; L Gallon
Journal:  Am J Transplant       Date:  2011-07-27       Impact factor: 8.086

3.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.

Authors:  M Lapsley; F V Flynn; P A Sansom
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

4.  Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation.

Authors:  Josh Levitsky; Sumeet K Asrani; Goran Klintmalm; Thomas Schiano; Adyr Moss; Kenneth Chavin; Charles Miller; Kexin Guo; Lihui Zhao; Linda W Jennings; Merideth Brown; Brian Armstrong; Michael Abecassis
Journal:  Hepatology       Date:  2020-01-28       Impact factor: 17.425

5.  Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats.

Authors:  Slava Malatiali; Issam Francis; Mario Barac-Nieto
Journal:  Exp Diabetes Res       Date:  2008

6.  Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis.

Authors:  Shiva Kalantari; Mohsen Nafar; Shiva Samavat; Mostafa Rezaei-Tavirani; Dorothea Rutishauser; Roman Zubarev
Journal:  Nephrourol Mon       Date:  2014-03-09

7.  Urinary β-trace protein: A unique biomarker to screen early glomerular filtration rate impairment.

Authors:  Carlo Donadio; Laura Bozzoli
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.